Eluceda Overview
- Founded
-
2009
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$2.45M
- Investors
-
2
Eluceda General Information
Description
Developer of biosensors designed to detect bacteria. The company's biosensors operate in a wide variety of environments and making sensors truly democratic and ubiquitous contributing to reducing product counterfeiting, speeding up drug production, making production safer and analyzing waste streams, enabling bio-pharmaceutical firms to detect markers in a wide variety of harsh chemicals.
Contact Information
Primary Industry
Biotechnology
Other Industries
Decision/Risk Analysis
Diagnostic Equipment
Primary Office
- Unit 3 Caroline Court
- Billington Road
- Burnley BB11 5UB
- England, United Kingdom
Eluceda Timeline
Eluceda Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Angel (individual) | 07-Jul-2021 | $2.45M | 00.00 | 0000 | Completed | Generating Revenue |
| 2. Angel (individual) | 14-Sep-2020 | 00000 | 00000 | 000.00 | Completed | Generating Revenue |
| 1. Grant | 01-Jun-2015 | $35.2K | Completed | Generating Revenue |
Eluceda Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Dummy | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| Ordinary | 000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
| Ordinary | 3,915 | $0.139394 | $529.85 | $529.85 | 1x | $529.85 | 11.93% | |
| Ordinary | 1,773 | $0.139394 | $393.09 | $393.09 | 1x | $393.09 | 5.4% |
Eluceda Patents
Eluceda Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4058796-A1 | Electrochemical authentication method | Pending | 15-Nov-2019 | 000000000 | |
| GB-201916696-D0 | Electrochemical authentication method | Inactive | 15-Nov-2019 | ||
| EP-2956549-A1 | Assay for detecting a nucleic acid analyte in a biological sample | Active | 14-Feb-2013 | 0000000000 | |
| EP-2956549-B1 | Assay for detecting a nucleic acid analyte in a biological sample | Active | 14-Feb-2013 | 0000000000 | |
| GB-201302610-D0 | Assay for detecting an analyte in a biological sample | Inactive | 14-Feb-2013 | C12Q1/6825 |
Eluceda Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Matthew Harte | Managing Director & Board Member |
Eluceda Board Members (6)
| Name | Representing | Role | Since |
|---|---|---|---|
| Ian Eastwood | Eluceda | Board Member | 000 0000 |
| Jim Murray-Smith | Self | Chairman | 000 0000 |
| Matthew Harte | Eluceda | Managing Director & Board Member | 000 0000 |
| Neil Ivey | Eluceda | Board Member | 000 0000 |
Eluceda Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Eluceda Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Peter Cowley | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Innovate UK | Government | 000 0000 | 000000 0 |